Single-Dose Open-label Randomized Crossover, in Two Periods and in Two Sequences, Single-Center Comparative Bioequivalence Study of Two Formulations Lamotrigine, 100 mg Tablets (Pharmtechnology LLC, Republic of Belarus), and Lamictal®, 100 mg Tablets (GlaxoSmithKline Trading Closed Joint-Stock Company (CJSC), Russia), in Healthy Volunteers Under Fasting Conditions
Каталог · ЕАЭС
Клинические исследования и проекты
Pharmtechnology LLC · найдено 2
2 исследования
Завершено
Фаза I
Здоровые добровольцы
Россия
Lamotrigine; Lamictal · Pharmtechnology LLC
Завершено
Фаза I
Здоровые добровольцы
Россия
Montelukast; Singulair · Pharmtechnology LLC
Single-Dose Open-label Randomized Crossover, in Two Periods and in Two Sequences, Single-Center Comparative Bioequivalence Study of Montelukast, 5 mg Chewable Tablets (Pharmtechnology LLC, Republic of Belarus), and Singulair®, 5 mg Chewable Tablets (Merck Sharp & Dohme B.V., the Netherlands), in Healthy Volunteers Under Fasting Conditions